drugset / Trial / NCT00250341

Non-invasive Measures of Distal Lung Disease in Asthmatics

NCT00250341

Phase 4 Completed 34 enrolled Teva Branded Pharmaceutical Products R&D, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Timeline

Start
2005-09-30
Primary completion
2007-09-30
Completion
2007-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 50 ug
Comparator Fluticasone propionate Other / unclassified 250 ug
Subject Servent Diskus Unknown 50 ug
Subject beclomethasone dipropionate Other / unclassified 480 ug

Indications